Base editing as a therapeutic strategy for repeat expansion diseases
@NatureGenet
nature.com/articles/s41...
Base editing as a therapeutic strategy for repeat expansion diseases
@NatureGenet
nature.com/articles/s41...
CRISPR-engineered CAR T cells targeting senescence-associated uPAR
Clear, compelling science—and a great discussion that followed. Exciting to see where this work is headed.
#CRISPR #CellTherapy
@warfnews.bsky.social
CRISPR-engineered CAR T cells targeting senescence-associated uPAR
Clear, compelling science—and a great discussion that followed. Exciting to see where this work is headed.
#CRISPR #CellTherapy
@warfnews.bsky.social
“Who’s Afraid of Off-Target Editing?”
1:30–3:15 PM CT (Room 293–296)
With Claire Clelland (UCSF) & Kiran Musunuru (Penn) of
@somaticediting Join us! #GenomicMedicine
“Who’s Afraid of Off-Target Editing?”
1:30–3:15 PM CT (Room 293–296)
With Claire Clelland (UCSF) & Kiran Musunuru (Penn) of
@somaticediting Join us! #GenomicMedicine
www.cell.com/molecular-th...
www.cell.com/molecular-th...
#CRISPR
ghi.wisc.edu/science-is-g...
#CRISPR
ghi.wisc.edu/science-is-g...
#CRISPR
ghi.wisc.edu/science-is-g...
📍 @DiscoveryBldg
🔗 DM for Zoom link!
#CRISPR
📍 @DiscoveryBldg
🔗 DM for Zoom link!
#CRISPR
@dcapps123 5/14: 2pm, Towards Efficient and Scalable Manufacturing of Genome-Edited CRISPR CAR T Cells
@Shankar_K2 5/16: 2pm, Development of human natural killer cell-based immunotherapies via genome eng.
@dcapps123 5/14: 2pm, Towards Efficient and Scalable Manufacturing of Genome-Edited CRISPR CAR T Cells
@Shankar_K2 5/16: 2pm, Development of human natural killer cell-based immunotherapies via genome eng.
A Question of Beginnings: Lab Embryos Between Nature and Synthesis
with @jacob_hanna, @cartersnead, @ArnoldEisen, @SJasanoff, @JudyNorsigian, @jdhardin1959 + many more.
@GenomeObserv
Registration:
A Question of Beginnings: Lab Embryos Between Nature and Synthesis
with @jacob_hanna, @cartersnead, @ArnoldEisen, @SJasanoff, @JudyNorsigian, @jdhardin1959 + many more.
@GenomeObserv
Registration: